Follow our Journey

Over 600 registered and counting, with just a few spots remaining. Featuring 12+ speakers, 30+ exhibitors from leading universities, research organisations...

Our CEO/Founder, Mark P. Waller, recently had an opportunity to visit major pharmaceutical sites across China. Tours of XtalPi Inc. and Salubris Pharmaceuticals Ltd. in Shenzen were particularly noteworthy...

This week, we are thrilled to feature David Almeida Cardoso, PhD , Vice President of Business Development & Strategy at Pending AI. David and his team are at the forefront...

Pending AI were pleased to be invited to the inaugural IBM-affiliated Asia-Pacific Healthcare and Life Sciences (HCLS) Quantum Working Group All Hands meeting at The University of Queensland, Australia...

Exciting news for drug discovery teams: Pending AI's Model Context Protocol (MCP) server is now live. We built this for medicinal chemists and computer-aided drug designers who want their AI assistan...

Pending AI are excited to announce that our long-standing collaboration with Elsevier has been renewed for the next five years. The combination of Elsevier's high-quality and well-curated dataset of ...

Pending AI is excited to announce the latest publication from our long standing collaborative project in Nature Communications (https://lnkd.in/gDmhrRMD) – AQuaRef, where machine learning is leveraged...

Pending AI were recently invited to participate in Quantum Futures in Healthcare – this intimate workshop brought together leaders from academia, industry, and government to candidly discuss the appli...

Pending AI are excited to announce our official rebrand - as we move towards the global forefront of integrating scalable artificial intelligence and quantum mechanical workflows into pharmaceutical...

Our CEO/Founder, Mark P. Waller, and Senior Site Reliability Engineer, Sam Fulton, recently had the pleasure of receiving a guided tour of the National Computational Infrastructure in Canberra, Australia...

Pending AI are looking forward to reconvening this week with representatives from world-leading pharmaceutical companies, investment firms and research institutes to discuss integration of quantum technology...

In the International Year of Quantum, we’re showing what it means to bring quantum to life! At our annual Themes Workshop, 60+ researchers from across...

We are excited to announce that Pending AI has been selected as a Spoke Member of the Investor Catalyst Hub, a highly competitive US-focused health innovation network launched by the Advanced Research...

Meet the minds pushing the edge of AI, healthcare, hiring, and engineering, and catch them live at Startup Boston Week 2025, happening September 8 - 12 at Suffolk University - Sawyer Business School...

Following their Illinois visit, JETRO invited the Japanese quantum delegation to Massachusetts to learn from major research institutions, universities, and companies to deepen connections between U.S....

🎉 A full room. A stunning venue. A surge of ideas. A community that’s truly moving. Our AI in Drug Discovery & Healthcare Mini-Conference took place last night at the Microsoft NERD Center in Cambridge...

Just over a week ago, DrugBank partnered with our friends at Pending AI in Boston to bring together a unique group of esteemed biotech and pharma executives for an evening of conversation, connection,...

Pending AI were recently invited to participate in the JETRO - Japan External Trade Organization Quantum Delegation to the United States. We had the opportunity to present our AI/QM discovery platform...

Fantastic start to the Convergence Center for Applied Quantum Computing Salon Series with a rapid fire discussion of "Where is the ROI Today" in applied quantum computing for the life sciences. Thanks...

Our strategic partner, Elsevier | Life Sciences, are coordinating their Global Reaxys User Day 2025 this week. The Pending AI Retrosynthesis Engine, trained on Elsevier's proprietary chemical reaction...